Published on

Medicine – Primary HIV Infection (Acute HIV Infection)

Primary HIV infection, also known as acute HIV infection or acute retroviral syndrome, represents the earliest phase of HIV infection following viral acquisition.

During this period, HIV replicates rapidly, producing high levels of circulating virus and triggering an immune response.

Symptoms typically develop approximately 2–4 weeks after exposure, although the timing varies between individuals.

Important Clinical Principle

Primary HIV infection may resemble infectious mononucleosis or influenza. HIV RNA and p24 antigen may become detectable before HIV antibodies, allowing earlier diagnosis.

1. Clinical Features of Primary HIV Infection

Approximately 40–90% of individuals develop symptoms of acute HIV infection, depending on the population studied and how symptoms are assessed. Older textbooks commonly quote approximately 50%.

The illness is usually characterised by a combination of constitutional, gastrointestinal, neurological, mucocutaneous and lymphatic manifestations.

A. Constitutional Symptoms

  • Fever: One of the most common manifestations.
  • Malaise: Generalised tiredness, weakness and fatigue.
  • Arthralgia: Joint pain, sometimes accompanied by myalgia.

B. Gastrointestinal Symptoms

  • Diarrhoea.
  • Nausea or vomiting.
  • Abdominal discomfort.

C. Neurological Manifestations

  • Headache.
  • Aseptic meningitis.
  • Occasionally meningoencephalitis.

Meningoencephalitis is an uncommon but important neurological manifestation of acute HIV infection.

D. Mucocutaneous Manifestations

  • Maculopapular rash, frequently involving the trunk.
  • Sore throat or pharyngitis.
  • Oral or oesophageal ulceration in some patients.

E. Lymphatic Manifestations

  • Generalised lymphadenopathy.
  • Cervical lymph node enlargement.
  • Axillary lymph node enlargement.

Illustration: Clinical Manifestations of Acute HIV Infection

Primary HIV Infection Acute retroviral syndrome Rapid Viral Replication Immune activation Constitutional Fever, malaise, arthralgia Gastrointestinal Diarrhoea, nausea Neurological Headache, meningitis Mucocutaneous Rash, sore throat Lymphatic Generalised lymphadenopathy
Examination Point: Fever, sore throat, maculopapular rash and generalised lymphadenopathy following a recent potential HIV exposure should raise suspicion of acute HIV infection.

2. Diagnosis of Primary HIV Infection

Diagnosis may be challenging because HIV antibodies are not immediately detectable after infection.

During early infection, HIV RNA and p24 antigen generally become detectable before HIV antibodies.

A. HIV Antibody Testing

Following HIV acquisition, the immune system produces antibodies against HIV antigens.

The period between infection and the point at which a diagnostic test can reliably detect infection is called the window period.

Older textbooks describe antibody seroconversion as potentially taking up to six months. However, this is not representative of modern HIV diagnostic testing.

Most people develop detectable HIV antibodies substantially earlier.

B. HIV RNA Detection by PCR / NAT

HIV RNA can be detected using nucleic acid testing (NAT), commonly employing amplification techniques such as reverse-transcription polymerase chain reaction (RT-PCR).

It is particularly useful when acute HIV infection is suspected but an antibody or antigen/antibody test is negative or inconclusive.

C. HIV p24 Antigen

The p24 antigen is a component of the HIV viral capsid.

It becomes detectable before HIV antibodies in many newly infected individuals.

Modern fourth-generation HIV screening assays detect both:

  • HIV-1/2 antibodies.
  • HIV-1 p24 antigen.

This allows earlier diagnosis than antibody-only testing.

3. HIV Diagnostic Window Period

Different HIV tests become positive at different times after infection.

The approximate detection windows below are commonly cited CDC ranges for testing in the absence of antiretroviral medication.

Comparison of HIV Testing Windows

Test Approximate Detection Window Main Target
HIV RNA NAT 10–33 days Viral RNA
Laboratory fourth-generation Ag/Ab 18–45 days p24 antigen and antibodies
Rapid fingerstick Ag/Ab 18–90 days Antigen and antibodies
Antibody-only tests 23–90 days HIV antibodies

Illustration: HIV Testing Window Periods

HIV Test Detection Windows Days after exposure 0 30 60 90 HIV RNA NAT Lab 4th-gen Ag/Ab Rapid Ag/Ab Antibody-only 10–33 18–45 18–90 days 23–90 days Approximate test-dependent detection windows

These ranges are not guarantees for every individual. PrEP or PEP may alter test detectability and require a modified testing strategy.

Examination Point: HIV RNA is generally detectable earlier than p24 antigen, which is generally detectable earlier than HIV antibodies.

4. Interpretation of Early HIV Tests

Test Result Possible Interpretation
HIV RNA positive, antibody negative Very early HIV infection is possible
p24 antigen positive, antibody negative Early HIV infection is possible
Fourth-generation Ag/Ab reactive Requires recommended confirmatory testing
Antibody positive with confirmatory evidence HIV infection confirmed
Early negative screening test Does not exclude recent HIV acquisition

An initially reactive screening test should be followed by the recommended supplemental tests, such as an HIV-1/HIV-2 antibody differentiation assay and HIV-1 RNA testing when indicated.

If acute infection is suspected despite negative initial testing, HIV RNA testing and appropriate repeat testing are important.

5. Diagnostic Approach to Suspected Acute HIV Infection

Suspected Acute HIV Infection Recent exposure or compatible symptoms Laboratory 4th-Generation HIV Ag/Ab Test Reactive Nonreactive Supplemental Differentiation Test RNA test when indicated If Acute HIV Is Still Suspected Obtain HIV RNA NAT Interpret Results Together Confirm infection or arrange appropriate repeat testing Simplified educational pathway

The exact testing algorithm depends on the laboratory assay, clinical context, local guidelines and whether the patient has received antiretroviral medication.

6. Management of Primary HIV Infection

Antiretroviral therapy (ART) is recommended for all people diagnosed with HIV, including during acute infection.

Benefits of Early ART

  • Suppresses viral replication.
  • Preserves immune function.
  • Reduces the risk of disease progression.
  • Reduces onward transmission.
  • May limit the size of the viral reservoir, although it does not cure HIV.

If a potential HIV exposure occurred within the previous 72 hours, urgent assessment for post-exposure prophylaxis (PEP) is indicated rather than waiting for symptoms or positive testing.

Clinical Safety Note

A negative HIV test during the window period does not exclude recent infection. Testing and follow-up should account for the type of assay, exposure timing and any PrEP or PEP use.

7. High-Yield Examination Summary

Feature Key Point
OnsetUsually 2–4 weeks after acquisition
Frequency of symptomsVariable; older texts often quote approximately 50%
Common symptomsFever, malaise, rash, sore throat, lymphadenopathy, arthralgia
Neurological complicationAseptic meningitis; occasionally meningoencephalitis
Earliest routinely detectable markerHIV RNA
Early viral protein markerp24 antigen
Modern screeningFourth-generation HIV Ag/Ab assay
Window periodDepends on the type of test
TreatmentInitiate ART as soon as feasible after diagnosis

8. Key Examination Pearls

  • Primary HIV infection can resemble infectious mononucleosis.
  • Approximately 50% develop seroconversion illness in older textbook descriptions.
  • Fever, rash, sore throat and lymphadenopathy are characteristic findings.
  • HIV RNA may be detectable before p24 antigen and antibodies.
  • A negative antibody test does not exclude very recent infection.
  • The historical six-month window period should not be applied to modern fourth-generation testing.
  • Early ART is recommended following diagnosis.
Most Important Examination Point

In suspected primary HIV infection, a negative antibody test does not exclude infection during the window period. HIV RNA testing and fourth-generation antigen/antibody assays allow earlier diagnosis.

Clinical Note

This article is intended for medical education and examination revision. Symptoms alone cannot confirm or exclude HIV infection. Testing intervals and interpretation should follow current clinical guidelines.

Kembara Xtra – Medicine Revision Notes

Image description
0 Comments